BCHE and Alzheimer disease: The growing evidence of oxidative stress-mediated damages to the DNA, proteins and lipids during AD has prompted for the identification of new molecules that not only serve as cholinesterase inhibitors but also play a vital role in scavenging the free radicals formed during the pathogenesis of the disease.